A detailed history of Values First Advisors, Inc. transactions in Geron Corp stock. As of the latest transaction made, Values First Advisors, Inc. holds 30,674 shares of GERN stock, worth $122,389. This represents 0.08% of its overall portfolio holdings.

Number of Shares
30,674
Previous 27,006 13.58%
Holding current value
$122,389
Previous $114,000 21.93%
% of portfolio
0.08%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$4.17 - $4.99 $15,295 - $18,303
3,668 Added 13.58%
30,674 $139,000
Q2 2024

Jul 19, 2024

BUY
$3.1 - $5.09 $83,718 - $137,460
27,006 New
27,006 $114,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.